logo-loader

Canntab Therapeutics debuts shares on 'serendipitous' 4/20

Published: 23:00 20 Apr 2018 AEST

Jeff Renwick, CEO of Canntab Therapeutics (CSE: PILL) tells Proactive Investors that the company that produces oral marijuana tablets is going public on the same day it was incorporated two years ago, and a day that pot enthusiasts celebrate as "Weed Day."

Renwick says as part of the strategic initiative to go public, the company plans to roll out a product development line and will next execute its distribution plan.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

12 hours, 4 minutes ago